Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for USD 10.28 mn

The acquisition will enable the company to commercialise its registered generics drug products in the US market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news